| Today's Open | $46.18 |
|---|---|
| Previous Close | $46.40 |
| Daily Range | $45.87 - $47.22 |
| 52-Week Range | $30.64 - $47.48 |
| Market Cap | $77.1B |
| P/E Ratio | 52.13 |
| Dividend (Yield) | $1.40 (3.0%) |
| Ex-Dividend Date Dividend Pay Date |
04/03/13 05/01/13 |
| Volume | 8,164,669 |
| Average Daily Volume | 10,982,182 |
| Current FY EPS | $1.81 |
Sector
Healthcare
Industry
Drugs
Bristol-Myers Squibb Co. (BMY) Description
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website: http://www.bms.com/
News & Commentary
Wall Street Loves this New Immunotherapy Cancer Drug
Bristol-Myers Squibb gets a huge upgrade on the back of cancer-fighting immunotherapy drug nivolumab.Can Financial Innovation Unlock a Cure for Cancer?
Andrew W. Lo from the MIT Sloan School of Management has a rather Foolish idea for solving the world's biggest problems.
A roundup of the day's best performers within the S&P 500 and what their moves mean for investors.
BMY's Top Competitors
(1.14%)
(-0.31%)
(-0.99%)
(0.27%)